Immunic IMUX
NASDAQ IMUX
$8.64 -0.66 (-7.10%)
At close: Oct 1, 2026 · 4:00 PM EDT

Immunic (IMUX) Non Operating Income (2013 - 2026)

Updated

Immunic (IMUX) posted Non Operating Income of $1.23 million for Q2 2026, up 366.9% from $263,000 a year earlier and up 89.8% from the prior quarter.

Analysis

Immunic (IMUX) Non Operating Income (2013 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Non Operating Income at Immunic was $6.32 million, up 84.2% year-over-year; for FY2025, it came in at $6.06 million.

  • Annual Non Operating Income shows a five-year compound annual growth rate of 4.1% (FY2020 to FY2025).
  • In prior years, Immunic's Non Operating Income was -$2.46 million in FY2024, $5.61 million in FY2023, -$919,000 in FY2022 and -$1.28 million in FY2021.
  • Quarterly Non Operating Income has run from a low of -$5.7 million in Q1 2024 to a high of $4.03 million in Q4 2025 over five years.
  • On a year-over-year basis, Non Operating Income increased in three of the last seven quarters, with growth averaging 134.5%.
  • The strongest year-over-year quarter for Non Operating Income in the past five years was Q4 2025, with growth of 783.1%; the weakest was Q4 2021, with a decline of 82.3%.
  • According to Business Quant data, Non Operating Income for the three prior quarters was $647,000 (Q1 2026), $4.03 million (Q4 2025) and $414,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Immunic 395.38 Mn 395.38 Mn - 1.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.23 Mn
Mar 31, 2026 647,000.00
Dec 31, 2025 4.03 Mn
Sep 30, 2025 414,000.00
Jun 30, 2025 263,000.00
Mar 31, 2025 1.35 Mn
Dec 31, 2024 456,000.00
Sep 30, 2024 1.36 Mn
Jun 30, 2024 1.43 Mn
Mar 31, 2024 -5.70 Mn
Dec 31, 2023 1.81 Mn
Sep 30, 2023 801,000.00
Jun 30, 2023 1.02 Mn
Mar 31, 2023 1.98 Mn
Dec 31, 2022 853,000.00
Sep 30, 2022 -1.11 Mn
Jun 30, 2022 -1.29 Mn
Mar 31, 2022 627,000.00
Dec 31, 2021 536,000.00
Sep 30, 2021 -905,000.00
API Access

Immunic Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=IMUX&period=max&api_key=YOUR_API_KEY